Aug 13, 2020
BD to Present at UBS Genomics 2.0 and MedTech Innovations Virtual Summit
May 26, 2020
BD to Present at Jefferies Virtual Healthcare Conference
May 19, 2020
BD Announces Offerings of $1.5 billion of Common Stock and $1.5 billion of Depositary Shares Representing Interests in Mandatory Convertible Preferred Stock
Apr 28, 2020
BD Board Declares Dividend
Apr 19, 2020
ROSEN, NATIONAL INVESTOR COUNSEL, Reminds Becton, Dickinson and Company Investors of Important Deadline in Securities Class Action
Apr 13, 2020
BD Announces Second FDA Emergency Use Authorization, CE Mark for New COVID-19 Molecular Diagnostic for Global Use
Apr 06, 2020
BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call
Apr 03, 2020
BD, BioGX Announce FDA Emergency Use Authorization for New COVID-19 Diagnostic for Use in U.S.
Mar 31, 2020
BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19
Mar 13, 2020
BD Statement on White House Meeting on COVID-19 Testing
Mar 10, 2020
CerTest Biotec and BD Announce COVID-19 Diagnostic Test
Jan 27, 2020
BD Board Declares Dividends
Jan 23, 2020
BD Announces Webcast of Annual Meeting of Shareholders
Jan 09, 2020
BD Announces Live Webcast Of First Fiscal Quarter Earnings Conference Call
Jan 03, 2020
BD to Present at the 38th Annual J.P. Morgan Healthcare Conference
Nov 22, 2019
BD to Present at Evercore ISI 2nd Annual HealthCONx Conference
Nov 21, 2019
BD Launches Enhanced Antimicrobial Stewardship Analytics Capabilities
Nov 14, 2019
BD to Present at Jefferies 2019 London Healthcare Conference
Nov 12, 2019
BD Submits Pre-Market Approval Supplement to FDA for BD Onclarity(TM) HPV Test with Extended Genotyping Capabilities
Oct 03, 2019
BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call